We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current KOD market cap is 541.24M. The company's latest EPS is USD -4.9501 and P/E is -2.17.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -54.5M | -63.37M | -46.06M | -47.98M | -46.63M |
| Net Income | -50.01M | -59.52M | -43.04M | -45.12M | -43.95M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -49.19M | -136.01M | -267.05M | -341.38M | -277.32M |
| Net Income | -47.37M | -133.1M | -266.99M | -333.82M | -260.49M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 547.65M | 479.37M | 434.76M | 401.58M | 372.67M |
| Total Liabilities | 245.24M | 213.59M | 193.57M | 187.07M | 187.3M |
| Total Equity | 302.42M | 265.78M | 241.19M | 214.51M | 185.37M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 358.87M | 1.07B | 904.22M | 666.63M | 479.37M |
| Total Liabilities | 13.51M | 206.6M | 240.9M | 230.46M | 213.59M |
| Total Equity | 345.36M | 860.75M | 663.32M | 436.17M | 265.78M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -121.94M | -154.18M | -39.6M | -66.09M | -87.25M |
| Investing | 277.02M | 249.23M | -166k | -426k | -631k |
| Financing | 155k | 31k | 38k | 97k | 97k |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -39.15M | -83.43M | -182.27M | -206.46M | -154.18M |
| Investing | -137M | 104.83M | -38.8M | -336.51M | 249.23M |
| Financing | 299.69M | 717.38M | 8.18M | 1.9M | 31k |
| Market Cap | 541.24M |
| Price to Earnings Ratio | -2.17 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 1.98 |
| Price to Book Ratio | 2.13 |
| Dividend Yield | - |
| Shares Outstanding | 52.62M |
| Average Volume (1 week) | 401.33k |
| Average Volume (1 Month) | 492.97k |
| 52 Week Change | 235.02% |
| 52 Week High | 11.5999 |
| 52 Week Low | 2.185 |
| Spread (Intraday) | 0.07 (0.68%) |
| Company Name | Kodiak Sciences Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.kodiak.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
